Sirolimus treatment for vertebrobasilar dolichoectasia
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a drug called sirolimus can help treat vertebrobasilar dolichoectasia (VBD)—an abnormal widening of blood vessels in the back of the brain. You may qualify if you have VBD confirmed by imaging and have had a stroke or VBD-related symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have VBD confirmed by imaging (DSA, CTA, or MRA scans)
- You have never had VBD rupture or surgery for VBD
- You have had a stroke in the back of the brain OR have symptoms related to VBD
- You must take both blood-thinning and cholesterol-lowering medications together, or take neither
- You have normal liver, kidney, and blood cell counts
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a blood pressure medication called amiloride can help treat vertebrobasilar dolichoectasia (VBD)—a condition where blood vessels at the base of the brain become abnormally enlarged. The study focuses on patients who have VBD but haven't had a stroke or surgery related to it yet.
This trial tests if sirolimus, a medicine that may help reduce abnormal blood vessels, can prevent another brain bleed in people who recently had a bleed from a brainstem cavernoma. You would receive either sirolimus or a placebo to see if it works.
This trial studies a sirolimus drug-coated balloon to treat certain “forked” coronary artery blockages (bifurcation lesions). It aims to reduce re-narrowing of the artery and improve blood flow after the procedure.
This Phase 3 study tests whether sirolimus helps control complex vascular anomalies that have not responded to standard treatments. It also checks safety by monitoring blood tests, organ function, and overall health during treatment.
This trial studies whether sirolimus (Rapamune®) can reduce problems from severe arteriovenous malformations (tangled blood vessel connections). It may help shrink the abnormal vessels or improve symptoms, by testing the medicine in people with certain AVM types.
This trial tests if the drug sirolimus can help people with focal seizures (starting in one part of the brain) that don't improve with at least two other medications. It aims to reduce seizure frequency in adults aged 18 to 60.
Hear when a new Vertebrobasilar Dolichoectasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.